Entropy Neurodynamics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022
Revenue	1.91	1.58	1.33	-	-
Revenue Growth	20.53%	19.17%	-	-	-
Cost of Revenue	3.25	2.4	2.35	2.62	-
Gross Profit	-1.35	-0.82	-1.02	-2.62	-
Selling, General & Admin	3.15	4.24	1.7	2.45	4.59
Research & Development	-	-	-	-	3.3
Operating Expenses	3.51	4.33	3.5	2.45	8.2
Operating Income	-4.86	-5.15	-4.52	-5.07	-8.2
Interest Expense	-0.16	-0.01	-0.65	-0.79	-
Interest & Investment Income	0.16	0.01	0.02	0	0
Currency Exchange Gain (Loss)	-0	-0.04	-0.12	-	-0.15
EBT Excluding Unusual Items	-4.87	-5.19	-5.27	-5.85	-8.35
Asset Writedown	-	-0.14	-	-	-
Other Unusual Items	-	-	-2.1	-	-
Pretax Income	-4.87	-5.33	-7.37	-5.85	-8.35
Net Income	-4.87	-5.33	-7.37	-5.85	-8.35
Net Income to Common	-4.87	-5.33	-7.37	-5.85	-8.35
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	1,569	1,378	507	349	78
Shares Outstanding (Diluted)	1,569	1,378	507	349	78
Shares Change	13.79%	172.04%	45.33%	346.62%	51.73%
EPS (Basic)	-0.00	-0.00	-0.01	-0.02	-0.11
EPS (Diluted)	-0.00	-0.00	-0.01	-0.02	-0.11
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022
Free Cash Flow	-3.41	-7.9	-7.2	-4.03	-6.47
Free Cash Flow Per Share	-0.00	-0.01	-0.01	-0.01	-0.08
Gross Margin	-70.64%	-51.65%	-76.85%	-	-
Operating Margin	-254.97%	-325.49%	-340.38%	-	-
Profit Margin	-255.40%	-337.14%	-555.37%	-	-
Free Cash Flow Margin	-178.91%	-499.43%	-542.48%	-	-
EBITDA	-4.83	-5.09	-4.51	-	-
EBITDA Margin	-253.54%	-	-	-	-
D&A For EBITDA	0.03	0.05	0.01	-	-
EBIT	-4.86	-5.15	-4.52	-5.07	-8.2
EBIT Margin	-254.97%	-	-	-	-
Revenue as Reported	2.06	1.59	1.34	0	-